Skip to main content
. 2023 Nov 3;12(21):6916. doi: 10.3390/jcm12216916

Table 3.

Follow-up data.

Mean duration (months) 12 ± 7
AT/AF recurrences, n (%) 4/27 (87%)
AAD discontinuation, n (%) 23/31 (74%)
Delayed pericarditis, n 0
Delayed tamponade, n 0